{"id":"https://openalex.org/W7220387251","doi":"https://doi.org/10.64898/2026.09.30.26364376","title":"Prediction of ROR1 and CAV1 expression from whole-exome sequencing of tumor tissue and plasma cfDNA to infer the efficacy of B013 plus nab-paclitaxel in triple-negative breast cancer","display_name":"Prediction of ROR1 and CAV1 expression from whole-exome sequencing of tumor tissue and plasma cfDNA to infer the efficacy of B013 plus nab-paclitaxel in triple-negative breast cancer","publication_year":2026,"publication_date":"2026-10-05","ids":{"openalex":"https://openalex.org/W7220387251","doi":"https://doi.org/10.64898/2026.09.30.26364376"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.30.26364376","doi":"https://doi.org/10.64898/2026.09.30.26364376","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.30.26364376","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/05/2026.09.30.26364376.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/05/2026.09.30.26364376.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055848133","display_name":"Min Jiang","orcid":"https://orcid.org/0000-0002-1407-0961","observed_orcids":["https://orcid.org/0000-0002-1407-0961"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Min Jiang","raw_affiliation_strings":["State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Drug Clinical Trial Institution, Peking University Cancer Hospital & Institute, Beijing 100142, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Drug Clinical Trial Institution, Peking University Cancer Hospital & Institute, Beijing 100142, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157417342","display_name":"Dongming Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dongming Zhang","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018031047","display_name":"Yi-Ching Hsueh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi-Ching Hsueh","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157476222","display_name":"Yu Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yu Zhao","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China","Western Institute of Computing Technology, Chinese Academy of Sciences, Chongqing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]},{"raw_affiliation_string":"Western Institute of Computing Technology, Chinese Academy of Sciences, Chongqing, China","institution_ids":["https://openalex.org/I19820366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157475612","display_name":"Shuhua Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuhua Zhao","raw_affiliation_strings":["Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National Drug Clinical Trial Institution, Peking University Cancer Hospital & Institute, Beijing 100142, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National Drug Clinical Trial Institution, Peking University Cancer Hospital & Institute, Beijing 100142, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040977567","display_name":"\u5f20\u5f3a\u7956","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qiangzu Zhang","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157477052","display_name":"Min Huang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Huang","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157415950","display_name":"Panjun Gao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Panjun Gao","raw_affiliation_strings":["Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National Drug Clinical Trial Institution, Peking University Cancer Hospital & Institute, Beijing 100142, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National Drug Clinical Trial Institution, Peking University Cancer Hospital & Institute, Beijing 100142, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130248514","display_name":"Xiaohong Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaohong Liu","raw_affiliation_strings":["Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National Drug Clinical Trial Institution, Peking University Cancer Hospital & Institute, Beijing 100142, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National Drug Clinical Trial Institution, Peking University Cancer Hospital & Institute, Beijing 100142, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157448944","display_name":"Yuhan Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuhan Liu","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101633676","display_name":"Qihuang Jin","orcid":"https://orcid.org/0000-0002-7319-1157","observed_orcids":["https://orcid.org/0000-0002-7319-1157"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qihuang Jin","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":"https://orcid.org/0000-0002-7319-1157","affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157388801","display_name":"Wenbin Dong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenbin Dong","raw_affiliation_strings":["Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National Drug Clinical Trial Institution, Peking University Cancer Hospital & Institute, Beijing 100142, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), National Drug Clinical Trial Institution, Peking University Cancer Hospital & Institute, Beijing 100142, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157416958","display_name":"Jing Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Zhang","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157588086","display_name":"Ran Ran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ran Ran","raw_affiliation_strings":["Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157558163","display_name":"Ruyan Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ruyan Zhang","raw_affiliation_strings":["Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157390670","display_name":"Yanhui Fan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanhui Fan","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101242415","display_name":"Juntao Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juntao Xu","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104072170","display_name":"Guangming Tan","orcid":"https://orcid.org/0000-0002-6361-5948","observed_orcids":["https://orcid.org/0000-0002-6361-5948"]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I4210090176","display_name":"Institute of Computing Technology","ror":"https://ror.org/0090r4d87","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210090176"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Guangming Tan","raw_affiliation_strings":["Institute of Computing Technology, Chinese Academy of Sciences, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Computing Technology, Chinese Academy of Sciences, Beijing, China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210090176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157388339","display_name":"Chunli Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I4210090176","display_name":"Institute of Computing Technology","ror":"https://ror.org/0090r4d87","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210090176"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chunli Zhang","raw_affiliation_strings":["Institute of Computing Technology, Chinese Academy of Sciences, Beijing, China","Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Computing Technology, Chinese Academy of Sciences, Beijing, China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210090176"]},{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157390173","display_name":"Chunming Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I4210090176","display_name":"Institute of Computing Technology","ror":"https://ror.org/0090r4d87","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I4210090176"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chunming Zhang","raw_affiliation_strings":["Institute of Computing Technology, Chinese Academy of Sciences, Beijing, China","Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Computing Technology, Chinese Academy of Sciences, Beijing, China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I4210090176"]},{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101683850","display_name":"Gang Niu","orcid":"https://orcid.org/0000-0002-0548-197X","observed_orcids":["https://orcid.org/0000-0002-0548-197X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gang Niu","raw_affiliation_strings":["Phil Rivers Technology Ltd, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phil Rivers Technology Ltd, Beijing, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5101683850"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.053199999034404755,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ror1","display_name":"ROR1","score":0.9800000190734863},{"id":"https://openalex.org/keywords/caveolin-1","display_name":"caveolin-1","score":0.9959999918937683},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cell-free-dna","display_name":"cell-free DNA","score":0.7620000243186951},{"id":"https://openalex.org/keywords/whole-exome-sequencing","display_name":"exome sequencing","score":0.8679999709129333},{"id":"https://openalex.org/keywords/targeted-therapy-response-prediction","display_name":"targeted therapy response prediction","score":0.5950000286102295},{"id":"https://openalex.org/keywords/regression-models","display_name":"regression models","score":0.3569999933242798}],"concepts":[{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.6074000000953674},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5943999886512756},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5418000221252441},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48429998755455017},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.45890000462532043},{"id":"https://openalex.org/C2781335228","wikidata":"https://www.wikidata.org/wiki/Q19596321","display_name":"Circulating tumor DNA","level":3,"score":0.4334000051021576},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41769999265670776},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41609999537467957},{"id":"https://openalex.org/C2994119904","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Drug response","level":3,"score":0.4083999991416931},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.3732999861240387},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3531999886035919},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.35269999504089355},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.34040001034736633},{"id":"https://openalex.org/C132917006","wikidata":"https://www.wikidata.org/wiki/Q5250436","display_name":"Deep sequencing","level":4,"score":0.3156999945640564},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3111000061035156},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.30140000581741333},{"id":"https://openalex.org/C2776598434","wikidata":"https://www.wikidata.org/wiki/Q18035517","display_name":"SLCO1B1","level":5,"score":0.2976999878883362},{"id":"https://openalex.org/C3018260909","wikidata":"https://www.wikidata.org/wiki/Q1322871","display_name":"Exploratory analysis","level":2,"score":0.2906000018119812},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.2842000126838684},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.2831999957561493},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.2802000045776367},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2680000066757202},{"id":"https://openalex.org/C189206191","wikidata":"https://www.wikidata.org/wiki/Q222046","display_name":"Genomics","level":4,"score":0.266400009393692},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.2556999921798706},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.2549999952316284},{"id":"https://openalex.org/C3020404979","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk stratification","level":2,"score":0.2538999915122986},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2533999979496002},{"id":"https://openalex.org/C2779529041","wikidata":"https://www.wikidata.org/wiki/Q22349364","display_name":"Liquid biopsy","level":3,"score":0.25110000371932983}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.30.26364376","doi":"https://doi.org/10.64898/2026.09.30.26364376","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.30.26364376","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/05/2026.09.30.26364376.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.30.26364376","doi":"https://doi.org/10.64898/2026.09.30.26364376","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.30.26364376","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/05/2026.09.30.26364376.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220387251.pdf","grobid_xml":"https://content.openalex.org/works/W7220387251.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1975711182","https://openalex.org/W2166948894","https://openalex.org/W2260694511","https://openalex.org/W2273246571","https://openalex.org/W2517348684","https://openalex.org/W2755462565","https://openalex.org/W2765435739","https://openalex.org/W2806532541","https://openalex.org/W2806810105","https://openalex.org/W2900295924","https://openalex.org/W2990870977","https://openalex.org/W3041271367","https://openalex.org/W3176597278","https://openalex.org/W3213834237","https://openalex.org/W4200570830","https://openalex.org/W4220957715","https://openalex.org/W4306392757","https://openalex.org/W4322736981","https://openalex.org/W4324017666","https://openalex.org/W4383874687","https://openalex.org/W4387846549","https://openalex.org/W4392166305","https://openalex.org/W4409212420","https://openalex.org/W4409962143"],"related_works":["https://openalex.org/W4415824694","https://openalex.org/W4220923218","https://openalex.org/W3195804632","https://openalex.org/W4220934794","https://openalex.org/W3208876955","https://openalex.org/W2589012388","https://openalex.org/W7162579726","https://openalex.org/W3171603182","https://openalex.org/W2246144684","https://openalex.org/W4393087567"],"abstract_inverted_index":{"Abstract":[0],"Accurate":[1],"prediction":[2,134,162],"of":[3,15,49,69,142,159],"response":[4,139,165],"to":[5,46,87,102,129],"targeted":[6],"anticancer":[7],"therapy":[8],"frequently":[9],"depends":[10],"on":[11],"the":[12,16,74,136,157],"expression":[13,37,85,161],"level":[14],"drug":[17],"target.":[18],"However,":[19],"transcriptomic":[20],"profiling":[21],"requires":[22],"tumor":[23,108],"tissue":[24,109],"that":[25],"is":[26],"often":[27],"unavailable,":[28],"and":[29,79,94,125,167],"circulating":[30],"cell-free":[31],"DNA":[32],"(cfDNA)":[33],"sequencing":[34,62],"carries":[35],"no":[36],"information.":[38],"Here,":[39],"in":[40,42,54,140],"an":[41],"silico":[43],"companion":[44],"study":[45],"a":[47,150],"trial":[48,104],"ROR1":[50,93,124],"antibody":[51],"plus":[52],"nab-paclitaxel":[53],"triple-negative":[55],"breast":[56],"cancer":[57],"(TNBC),":[58],"we":[59],"transformed":[60],"whole-exome":[61],"(WES)":[63],"data":[64,86],"into":[65],"somatic":[66],"activity":[67],"profiles":[68],"signaling":[70],"pathways":[71],"(sAPSPs)":[72],"using":[73],"previously":[75],"published":[76],"DAGM":[77],"framework,":[78],"used":[80],"them":[81],"together":[82],"with":[83,107,112],"matched":[84,135],"develop":[88],"regression":[89],"model":[90,98],"sets":[91,99],"predicting":[92],"CAV1":[95,126],"expression.":[96],"The":[97,133],"were":[100,117,127],"applied":[101],"10":[103,143],"participants":[105],"(4":[106],"WES,":[110],"6":[111],"plasma":[113],"cfDNA":[114],"WES).":[115],"Patients":[116],"classified":[118],"as":[119],"predicted-sensitive":[120,147],"only":[121],"when":[122],"both":[123],"predicted":[128],"be":[130],"highly":[131],"expressed.":[132],"observed":[137],"best":[138],"9":[141],"patients;":[144],"all":[145],"three":[146],"patients":[148],"achieved":[149],"partial":[151],"response.":[152],"These":[153],"exploratory":[154],"findings":[155],"support":[156],"feasibility":[158],"WES-based":[160],"for":[163],"non-invasive":[164],"stratification":[166],"warrant":[168],"prospective":[169],"validation.":[170]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-06T00:00:00"}